Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Sarepta Therapeutics
(NQ:
SRPT
)
160.72
+37.22 (+30.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
15,050,158
Open
161.97
Bid (Size)
161.76 (4)
Ask (Size)
162.48 (1)
Prev. Close
123.50
Today's Range
157.25 - 173.25
52wk Range
55.25 - 173.25
Shares Outstanding
93,148,652
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Google Parent Alphabet At All-Time High, In Stock Spotlight: See New Names On IBD 50, Stock Spotlight And More
June 21, 2024
Alphabet stock has more than doubled since February 2023 and it continues to outperform. It boasts a best-possible 99 Composite Rating.
Via
Investor's Business Daily
Growth Stocks Leave Value Stocks In The Dust: 4 Reasons For Biggest Monthly Lead In Over A Year
June 21, 2024
Technology sector dominates growth stocks, boosted by strong earnings and investor confidence. Value stocks struggle due to less impressive performance and subdued earnings expectations. Growth...
Via
Benzinga
Performance
YTD
+67.05%
+67.05%
1 Month
+25.27%
+25.27%
3 Month
+26.02%
+26.02%
6 Month
+70.00%
+70.00%
1 Year
+29.70%
+29.70%
More News
Read More
Nasdaq Moves Lower; FactSet Research Posts Upbeat Earnings
June 21, 2024
Via
Benzinga
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 21, 2024
Via
Benzinga
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty
June 21, 2024
Via
Benzinga
Stocks Stall As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
June 21, 2024
Via
Benzinga
Sarepta's Expanded FDA Approval For Elevidys Potentially Shaping Future FDA Reviews, Analyst Says
June 21, 2024
Via
Benzinga
Exposures
Product Safety
Gold Down 1%; CarMax Shares Gain After Q1 Earnings
June 21, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Sarepta Therapeutics Through 9 Analysts
June 14, 2024
Via
Benzinga
Why Is Ascent Solar (ASTI) Stock Up 11% Today?
June 21, 2024
Via
InvestorPlace
Why Is 36Kr (KRKR) Stock Up 17% Today?
June 21, 2024
Via
InvestorPlace
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
June 21, 2024
Via
Benzinga
Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance
June 21, 2024
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Pre-Market Movers - June 21, 2024
June 21, 2024
Via
Talk Markets
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
June 21, 2024
Via
InvestorPlace
Exposures
Product Safety
Apple To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday
June 21, 2024
Via
Benzinga
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
June 21, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 21, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 21, 2024
Via
InvestorPlace
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
June 21, 2024
Via
Benzinga
Exposures
Product Safety
Wall Street Looks Set For Modestly Lower Start Ahead Of Key Data, Tech Stocks Muted In Premarket: Analyst Says 'Bearish Sentiment Has Become Understandably Quiet'
June 21, 2024
Via
Benzinga
Sarepta Skyrockets After Nabbing A Broad Label For Its Duchenne Gene Therapy
June 20, 2024
Via
Investor's Business Daily
Sarepta Therapeutics Announces Expanded US FDA Approval of ELEVIDYS to Duchenne Muscular Dystrophy Patients Ages 4 and Above
June 20, 2024
From
Sarepta Therapeutics, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
June 19, 2024
Via
Benzinga
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
June 13, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.